Mereo BioPharma Group Market Sentiment

Market sentiment signals for Mereo BioPharma Group (MREO): analyst consensus, short interest, options flow and insider activity.

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 19, 2026	JP Morgan	Priyanka Grover—	—	—	Downgrade	Neutral→Underweight
Aug 11, 2026	BTIG	Julian Harrison—	+288.3%	$1 → $1	Maintained	Buy
Aug 11, 2026	Needham	Gil Blum—	+1065.0%	$3 → $3	Maintained	Buy
May 12, 2026	BTIG	Julian Harrison—	+288.3%	$1 → $1	Maintained	Buy
Mar 23, 2026	JP Morgan	Priyanka Grover—	—	—	Downgrade	Overweight→Neutral
Jan 16, 2026	BTIG	Julian Harrison—	+288.3%	$1 → $1	Maintained	Buy
Jan 13, 2026	Needham	Gil Blum—	+1065.0%	$5 → $3	Maintained	Buy
Dec 30, 2025	Jefferies	Maury Raycroft—	+94.2%	$7 → $1	Downgrade	Buy→Hold
Dec 29, 2025	BTIG	Julian Harrison—	+288.3%	$6 → $1	Maintained	Buy
Dec 29, 2025	LifeSci Capital	Cory Jubinville—	—	—	Downgrade	Outperform→Market Perform
Dec 22, 2025	Needham	Gil Blum—	+1841.7%	$5 → $5	Maintained	Buy
Dec 18, 2025	BTIG	Julian Harrison—	+2230.1%	$6 → $6	Maintained	Buy
Aug 25, 2025	JP Morgan	Priyanka Grover—	+3006.8%	$7 → $8	Maintained	Overweight
Jul 10, 2025	Needham	Gil Blum—	+1841.7%	$7 → $5	Maintained	Buy
May 13, 2025	Needham	Gil Blum—	+2618.4%	$7 → $7	Maintained	Buy
Apr 9, 2025	Needham	Gil Blum—	+2618.4%	$7 → $7	Maintained	Buy
Mar 27, 2025	JP Morgan	Priyanka Grover—	+2618.4%	$7	Initiate	Overweight
Mar 26, 2025	Needham	Gil Blum—	+2618.4%	$7 → $7	Maintained	Buy
Mar 18, 2025	Cantor Fitzgerald	Kristen Kluska—	+2618.4%	$7 → $7	Maintained	Overweight
Jan 13, 2025	Needham	Gil Blum—	+2618.4%	$7 → $7	Maintained	Buy
Dec 24, 2024	LifeSci Capital	Cory Jubinville—	+3783.5%	$10	Initiate	Outperform
Dec 17, 2024	Needham	Gil Blum—	+2618.4%	$7 → $7	Maintained	Buy
Dec 6, 2024	Jefferies	Maury Raycroft—	+2618.4%	$7	Initiate	Buy
Nov 12, 2024	Needham	Gil Blum—	+2618.4%	$7 → $7	Maintained	Buy
Oct 1, 2024	Cantor Fitzgerald	Kristen Kluska—	+2618.4%	$7 → $7	Maintained	Overweight